SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the
Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
SHENZHEN,China,Feb. 25,2025--Pudu Robotics,a global leader in service robotics,is revolutionizing cleanliness standards at Ryugujo Spa Hotel Mikazuki Ryugutei in Japan,a renowned Japanese hot spring
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial,recommending continued progression as planned
DUBAI,UAE,Feb. 25,2025-- Emirates,as the international airline based in Dubai,has announced its first series of pilot recruitment roadshows in Macao Special Administrative Region,China to meet the str
XUZHOU,China,Feb. 25,2025--The 3rd XCMG & FinDreams Super Battery Day was successfully held at the XCMG International Conference Center,Xuzhou,focused on cutting-edge technologies and explored new
LAS VEGAS,Feb. 26,2025-- GoldenHome,a global leader in custom home solutions,is showcasing its latest collection of cabinets and closets featuring smart and contemporary design aesthetics at the 2025
NEW YORK,Feb. 25,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight
HONG KONG and SHANGHAI,Feb. 21,2025--Fosun\'s global operations achieved another milestone. On February 20,during the Abu Dhabi Investment Forum in Shanghai,Fosun International signed a Memorandum of
Higher Salaries,Strong Internship-to-Employment Pipeline,and Industry Demand Drive Graduate Success SINGAPORE,Feb. 24,2025-- The latest Graduate Employment Survey (GES) 2024 underscores Singapore Man
Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.
©Copyright 2009-2020 Startup Weekly Contact Us SiteMap